Screener
Candel Therapeutics, Inc. CADL Free cash flow margin
Discontinued — last reported Q4 '22
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024. Open the filing →
- Filed
- Mar 28, 2024
- Fiscal year
- FY2023
- Accession
- 0000950170-24-037637
FAQ
- What is Candel Therapeutics, Inc.'s free cash flow margin?
- Candel Therapeutics, Inc. (CADL) reported free cash flow margin of -26,383.9% in Q4 2022.
- How has Candel Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Candel Therapeutics, Inc.'s free cash flow margin decreased by 36.0% year-over-year, from -19,397.6% to -26,383.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Candel Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude